Teva CEO Calls 'Trough' Revenues Consequence of Patent Expirations - YouTube
Watch CNBC's full interview with Teva CEO Kåre Schultz
Troubled Teva appoints new CEO in bid for direction | The Times of Israel
A Look At Kare Schultz, The New CEO In Charge Of Teva
Kåre Schultz new CEO of Teva - Nordic Life Science – the leading Nordic life science news service
Teva CEO Sees a Final Opioid Settlement Coming This Year | Barron's
Kåre Schultz - Disability:IN
Teva Pharmaceuticals on Twitter: "Speaking at #JPM2020, Teva CEO Kåre Schultz discussed the company's restructuring, future growth drivers, and a focus on the needs of patients and customers. Listen to a replay
Parsippany-based Teva reaches $225M opioid settlement with Texas - NJBIZ
Teva CEO steps down, replacement found
Teva neck-deep in legal trouble with no end in sight | Ctech
Teva Pharmaceuticals CEO Kare Schultz testifies by video conference during a hearing before the US House of Representatives Committee on Oversight and Reform focused on the cost of prescription drugs, in the
Teva finally nabs a CEO, and it's Lundbeck helmsman—and Novo ex—Kåre Schultz | Fierce Pharma
Teva Appoints Lundbeck's Schultz as CEO | Ctech
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Teva names Kåre Schultz as new CEO
Teva CEO Kare Schultz Says Drugmaker Will Fight US Price-Fixing Charges - Bloomberg
Serial Problem Solver
Teva Pharmaceuticals on Twitter: "Our live Q2 2022 earnings call is starting soon! Join President & CEO Kåre Schultz to discuss Teva's business performance and plans ahead. Join here: https://t.co/VR9FyBqEz2 #QuarterlyResults #Earnings $
Teva Investors Are Back on the Rollercoaster | Ctech
Teva Names Kåre Schultz as President and Chief Executive Officer » FINCHANNEL
Teva CEO Kåre Schultz discusses company's latest quarter and opioid settlement - YouTube
Reuters Spotlight on Kåre Schultz, CEO Teva Pharmaceuticals - YouTube
Serial Problem Solver
Kåre Schultz - Disability:IN
